Establishment and metabonomics analysis of nonalcoholic fatty liver disease model in golden hamster
Author:
Zhao Cui-Zhu1, Jiang Lin2, Li Wen-Yan1, Wu Guang2, Chen Jie3, Dong Li-Hua2, Li Min1, Jiang Wei1, Zhu Ji-Xiao1, Gao Yan-Ping1, Ma Qin-Ge3ORCID, Zhong Guo-Yue1, Wei Rong-Rui1ORCID
Affiliation:
1. Research Center of Natural Resources of Chinese Medicinal Materials and Ethnic Medicine, Jiangxi University of Chinese Medicine , Nanchang 330004 , China 2. College of Pharmacy, Jiangxi University of Chinese Medicine , Nanchang 330004 , China 3. Key Laboratory of Modern Preparation of Traditional Medicine of Ministry of Education, Jiangxi University of Chinese Medicine , Nanchang 330004 , China
Abstract
Abstract
The aim is to establish a model of nonalcoholic fatty liver disease (NAFLD) caused by feeding with high-fat, high-fructose, and high-cholesterol diet (HFFCD) in golden hamsters, and to investigate the characteristics of the NAFLD model and metabolite changes of liver tissue. Golden hamsters were fed HFFCD or control diets for six weeks. Body weight, abdominal fat index, and liver index was assessed, serum parameters, hepatic histology, and liver metabolites were examined. The results showed that body weight, abdominal fat, and liver index of hamsters were significantly increased in the model group, the level of serum total cholesterol (TC), triglyceride (TG), and low density lipoprotein-cholesterol (LDL-C) were significantly increased in model group as well, and high density lipoprotein-cholesterol (HDL-C) was significantly decreased. In addition, lipid deposition in liver tissue formed fat vacuoles of different sizes. Metabonomics analysis of the liver showed that the metabolic pathways of sphingolipid, glycerophospholipids, and arginine biosynthesis were disordered in the NAFLD model. The modeling method is simple, short time, and uniform. It can simulate the early fatty liver caused by common dietary factors, and provides an ideal model for the study of the initial pathogenesis and therapeutic drugs for NAFLD.
Funder
Science and Technology Project of Jiangxi Health Commission Scientific Research Project of Jiangxi Administration of Traditional Chinese Medicine Jiangxi University of Chinese Medicine Graduate Innovation Fund State Scholarship Fund of China Scholarship Council Jiangxi Provincial Natural Science Foundation
Publisher
Walter de Gruyter GmbH
Subject
General Biochemistry, Genetics and Molecular Biology
Reference30 articles.
1. Toplak, H, Stauber, R, Sourij, H. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects. Diabetologia 2016;59:1148–9. https://doi.org/10.1007/s00125-016-3941-4. 2. Byrne, CD, Targher, G. NAFLD: a multisystem disease. J Hepatol 2015;62:47–64. https://doi.org/10.1016/j.jhep.2014.12.012. 3. Lonardo, A, Byrne, CD, Caldwell, SH, Cortez-Pinto, H, Targher, G. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73–84. https://doi.org/10.1002/hep.28584. 4. Wu, YK, Zheng, Q, Zou, BY, Yeo, YH, Li, XH, Li, J, et al.. The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis. Hepatol Int 2020;14:259–69. https://doi.org/10.1007/s12072-020-10023-3. 5. Chon, YE, Kim, KJ, Jung, KS, Kim, SU, Park, JY, Kim, DY, et al.. The relationship between type 2 diabetes mellitus and non-alcoholic fatty liver disease measured by controlled attenuation parameter. Yonsei Med J 2016;57:885–92. https://doi.org/10.3349/ymj.2016.57.4.885.
|
|